AstraZeneca PLC is 285.0x more valuable than Ventyx Biosciences, Inc. by market capitalization ($286.27 B vs $1.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VTYX | AZN |
|---|---|---|
| Market cap | $1.00 B | $286.27 B |
| US-listed rank | #2638 | #45 |
| Net income (latest FY) | -$135.12M | - |
| SEC filings | 495 | 1,004 |
AstraZeneca PLC is 285.0x more valuable than Ventyx Biosciences, Inc. by market capitalization ($286.27 B vs $1.00 B).
Full pages: Ventyx Biosciences, Inc. and AstraZeneca PLC, or browse the full rankings.